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ABSTRACT 
A method for non-invasive visualization of genetically labelled cells in animal disease 
models with micron-level resolution would greatly facilitate development of cell-based 
therapies. Imaging of fluorescent proteins (FPs) using red excitation light in the “optical 
window” above 600 nm is one potential method for visualizing implanted cells. However, 
previous efforts to engineer FPs with peak excitation beyond 600 nm have resulted in 
undesirable reductions in brightness. Here we report three new red-excitable monomeric 
FPs obtained by structure-guided mutagenesis of mNeptune, previously the brightest 
monomeric FP when excited beyond 600 nm. Two of these, mNeptune2 and mNeptune2.5, 
demonstrate improved maturation and brighter fluorescence, while the third, mCardinal, 
has a red-shifted excitation spectrum without reduction in brightness. We show that 
mCardinal can be used to non-invasively and longitudinally visualize the differentiation of 
myoblasts and stem cells into myocytes in living mice with high anatomical detail. 
 
  
INTRODUCTION 
 Mammalian tissues are relatively transparent to red wavelengths of light within the 
“optical window” (600-1000 nm), where hemoglobin and myoglobin absorbances are relatively 
low (Fig. 1a)1,2. Compared to bluer wavelengths, red light also generates less tissue 
autofluorescence from excitation of NAD(P)H, flavins, and lipofuscin3. FPs that can be excited 
by red light are therefore useful as genetically encoded markers for non-invasive deep-tissue 
imaging in mammals4. Monomeric FPs are particularly desirable, as they can be fused to other 
protein domains to create reporters of biochemical pathways or cellular states5,6. Monomeric FPs 
that can be excited in the optical window include conventional autocatalytic far-red FPs7-9, the 
light-induced far-red fluorescent form of PSmOrange10, and the bacteriophytochrome-based 
infrared fluorescent protein, IFP1.411.  
 Of these, the autocatalytic far-red FPs have practical advantages for in vivo imaging. 
Most of them are brighter than the far-red form of PSmOrange10 or IFP1.411. Furthermore, they 
can mature in the dark, unlike PSmOrange, and independent of trans-acting factors, unlike 
IFP1.4. We previously engineered mNeptune, derived from eqFP578 of Entacmaea quadricolor, 
as a bright autocatalytic FP with peak excitation at 600 nm7. mNeptune has a large Stokes’ shift 
(50 nm) and intrinsic brightness (ε = 75 mM-1 cm-1, φ = 0.23 according to our recent 
measurements, Table 1) similar to the widely used red FP mCherry. Because subsequent efforts 
shifting the absorbance peak of FPs beyond 600 nm also resulted in decreased brightness12, 
mNeptune still generates higher fluorescence contrast over background than other monomeric 
and oligomeric autocatalytic FPs in living animals when excited with light beyond 620 nm10,13,14. 
Nevertheless, further red-shifting would be desirable if brightness can be maintained, as 
wavelengths of light beyond the hemoglobin absorbance tail could then be used for illumination.  
 In this study, we applied structure-guided mutagenesis to engineer both brighter and more 
red-shifted derivatives of mNeptune. The red-shifted variant, mCardinal, can be efficiently 
imaged in cells and organisms with 633-635 nm laser lines and enables orthogonal imaging with 
orange-red FPs. We used mCardinal to perform non-invasive visualization of muscle cell 
regeneration in living mice with high anatomical resolution. 
 
RESULTS 
Engineering of far-red fluorescent proteins 
 First, to improve chromophore maturation and packing, we mutagenized residues 
surrounding the chromophore. We also mutated Ile-171 in the former cross-dimer interface to 
reduce hydrophobicity that may be energetically unfavorable for monomer folding. After 
screening bacterial colonies for chromophore absorbance and maturation by visual inspection, 
and for fluorescence with 600-620 nm excitation and 630-660 nm emission filters, we obtained 
one variant with internal mutations A104V and I121L and external mutation I171H 
(Supplementary Fig. 1). This protein retained the excitation and emission spectra of mNeptune 
(Fig. 1b, 1c), but was 25% brighter (ε = 89 mM-1 cm-1, φ = 0.24). We named it mNeptune2 and 
designated the original mNeptune as mNeptune1. 
 We next performed mutagenesis to optimize a hydrogen bond interaction first introduced 
into FPs in mNeptune and its dimeric variant Neptune. In Neptune, a water molecule donates a 
hydrogen bond to the carbonyl oxygen in the acylimine portion of the chromophore7. This may 
have a bathochromic effect by preferentially stabilizing the excited state, in which electron 
density over the carbonyl oxygen is believed to be increased relative to the ground state. We 
hypothesized that substituting a genetically encoded hydrogen bond donor for the water molecule 
could improve brightness by reducing excited state vibrations that could lead to non-radiative 
decay, and/or cause further red-shifting by increasing the strength or uniformity of the hydrogen 
bond interaction. Saturation mutagenesis at positions in the beta barrel wall facing the acylimine 
oxygen (Fig. 2a) yielded one mutant that appeared brighter, mNeptune2 S28H G41N, and 
another that appeared red-shifted in absorbance, mNeptune2 S28T G41Q. We then mutagenized 
amino acids interacting with position 28, position 41, or the chromophore phenolate and selected 
for improved maturation. This yielded mNeptune2 M11T S28H G41N and mNeptune2 S28T 
G41Q S143T. The first protein, which we designated mNeptune2.5, is 25% brighter than 
mNeptune2 and 54% brighter than mNeptune1 (ε = 95 mM-1 cm-1, φ = 0.28), but is slightly blue-
shifted in excitation and emission (peak ex/em, 599/643 nm, Fig. 1b). The second protein is red-
shifted in excitation and emission (peak ex/em, 604/659 nm, Fig. 1b) while retaining the 
brightness of mNeptune1 (ε = 87 mM-1 cm-1, φ = 0.19). We named this protein mCardinal for its 
cardinal-red emission.  
 
Characterization of far-red fluorescent proteins 
 To understand the mechanism of red-shifting in mCardinal, we determined its structure at 
pH 7.5 to 2.2 Å resolution by X-ray crystallography (Supplementary Table 1). The structure 
revealed that, in place of the water molecule in Neptune (Fig. 2a), the amide group of Gln41 in 
mCardinal donates a hydrogen bond to the chromophore acylimine oxygen (Fig. 2b). The donor-
acceptor distance is shorter in mCardinal compared to Neptune (2.5 vs 2.8 Å), suggesting a 
stronger hydrogen bond15, which could provide additional stabilization of the excited state in 
mCardinal compared to Neptune. In addition, the Thr28 hydroxyl group of mCardinal appears to 
be engaged in a hydrogen bond with the Gln41 amide oxygen, positioning the amide nitrogen for 
hydrogen bonding to the chromophore acylimine oxygen. In Neptune, Ser28 served a similar role 
in positioning a water molecule to hydrogen-bond with the chromophore acylimine oxygen. To 
further confirm these findings, we also crystallized mCardinal with an external V218E mutation 
(introduced to reduce dimericity) in a different space group and solved its structure at 1.7 Å 
resolution (Supplementary Table 1). This second structure confirmed the presence of a new 
shorter hydrogen bond from Gln41 to the chromophore acylimine oxygen, as well a hydrogen 
bond between Thr28 and Gln41 (Fig. 2c). Thus, crystal structures of mCardinal validate our 
original design approach of introducing a stronger genetically encoded hydrogen bond to the 
acylimine oxygen. 
 mCardinal is more readily excitable at the common laser wavelength of 635 nm than 
mNeptune1 (ε 18 vs. 9.6 mM-1 cm-1). It also has at least 50% higher quantum yield above 635 nm 
than the monomeric TagRFP657, dimeric eqFP670, or tetrameric E2-Crimson (Table 1), 
previously described autofluorescent FPs with redder peak absorbance than mNeptune18,14. Thus 
mCardinal would be expected to be brighter than all other far-red FPs upon 635 nm excitation, 
even when collecting emission at infrared wavelengths beyond 700 nm (Supplementary Fig. 2a). 
In tests with purified proteins, mCardinal was indeed brighter upon excitation by 625-655 nm 
light than other autofluorescent proteins (Supplementary Fig. 2b). mCardinal was also brighter 
when excited by light beyond 670 nm (Supplementary Fig. 2b). However, the two-photon cross-
section of mCardinal may be smaller than that of mNeptune1, as mCardinal was dimmer at 
equivalent concentrations when excited at wavelengths from 800 to 1080 nm, the furthest 
possible with our Ti-Sapphire laser (Supplementary Fig. 3).  
 We characterized mNeptune2, mNeptune2.5, and mCardinal for chromophore maturation, 
pH stability, and photostability (Table 1). Compared to mNeptune1, the new FPs exhibit equal or 
faster red chromophore maturation at 37°C (Supplementary Fig. 4a), higher final maturation 
efficiency (Table 1), and reduced formation of a green fluorescent side-product that is common 
to eqFP578 derivatives and is especially high in TagRFP657 (Table 1, Supplementary Fig. 4b). 
The fluorescence of mCardinal was more resistant to acidic pH than the other mNeptune 
derivatives (Supplementary Fig. 4c). The new FPs were similar to mNeptune1 in monomeric 
character (Supplementary Fig. 4d), and improved in photostability under arc lamp illumination in 
vitro (Supplementary Fig. 5a). In cells under wide-field and laser illumination, mCardinal 
exhibited photostability between mKate2 and mNeptune1 (Supplementary Fig. 5b,c). All 
mNeptune-derived FPs exhibited an increase in fluorescence indicating photoactivation prior to 
photobleaching in vitro and in cells, with the exception of mNeptune1 in vitro. 
 We further assessed the performance of the new FPs in mammalian cells. We observed 
that mNeptune2 and mCardinal were approximately 20% and 50% brighter, respectively, than 
mNeptune1 in HeLa cells, while mNeptune2.5 was 35% dimmer (Supplementary Fig. 6). The 
difference between mCardinal and mNeptune1 is larger than expected from the spectral 
properties of purified proteins, indicating higher expression of mCardinal relative to mNeptune1 
in HeLa cells. Likewise, the lower brightness of mNeptune2.5 relative to mNeptune1 in cells 
despite being 40% brighter in vitro suggests lower expression. mNeptune2 and mCardinal 
perform well in primary neurons (Supplementary Fig. 7a), as well as in primary mouse 
myoblasts in both proliferating and differentiating states (Supplementary Fig. 7b). A variety of 
N-terminal and C-terminal fusions to mNeptune2 (Supplementary Fig. 8) or mCardinal 
(Supplementary Figs. 9 and 10) showed correct subcellular localization and could be imaged 
with high contrast with 633 nm excitation light.  
 
Performance of far-red fluorescent proteins in vivo 
 As the performance of mCardinal in all metrics matched or exceeded the other mNeptune 
variants, we proceeded to test mCardinal in animals. To determine if mCardinal could be used to 
provide an additional imaging channel beyond orange-red FPs, we created C. elegans worms 
expressing GFP::Rab-3 in neurons, synaptogyrin::mCardinal in neurons, and the orange-red 
DsRed in muscles. By epifluorescence microscopy, we observed the expected colocalization of 
punctate red and green fluorescence in synaptic vesicles apposed to the orange fluorescence of 
the body wall (Supplementary Fig. 11a), confirming that mCardinal is bright enough to label 
small subcellular structures and can be visualized orthogonally to orange-red FPs. To test the 
ability to visualize three different structures, we expressed GFP, mCherry, and mCardinal in 
primary epithelial cells, muscle cells, and secondary epithelial cells of the vulva, respectively. 
Each cell type was observed only in its expected channel (Supplementary Fig. 11b), indicating 
that the low amount of residual green fluorescence in mCardinal does not interfere with GFP 
imaging and that mCherry and mCardinal can also be visualized orthogonally. mCardinal thus 
provides another imaging channel that allows separation from common orange or orange-red FPs. 
 We tested whether mCardinal can be used for extended time-lapse microscopy or fast 
confocal microscopy. We continuously scanned mCardinal-expressing cells with a 633-nm laser 
at 60× magnification for over 20 minutes without apparent toxicity (Supplementary Videos 1 and 
2). In worms, we were able to visualize mCardinal in pharyngeal muscles during free movement 
and serotonin-induced pharyngeal contractions by confocal microscopy with a galvonometer-
driven 635-nm laser (Supplementary Videos 3 and 4). We observed no toxicity or 
photobleaching for over 200 frames while tracking the worms. Thus, 633-635 nm excitation light 
enables extended imaging of mCardinal without toxicity, and mCardinal is bright enough to 
allow for fast time-lapse confocal imaging in a multi-cellular organism. 
 
Deep-tissue imaging of cellular differentiation   
 As discussed, a primary motivation for developing far-red FPs is to perform deep-tissue 
imaging in mammals using excitation wavelengths above 600 nm, which penetrate through 
hemoglobin-rich tissues more easily than bluer light16. To directly compare the imaging 
performance of far-red FPs in deep tissue, we first imaged purified far-red proteins placed within 
the esophagus of an euthanized mouse using a commercial small-animal fluorescence imaging 
system. Imaged from the ventral side, this location is approximately 7 mm deep. With 605/30 nm 
excitation light (center wavelength/full width at half-maximum), a range that covers the 
excitation peaks of all tested FPs, mNeptune2.5 was the brightest (Fig. 3a), consistent with 
mNeptune2.5 having the highest peak brightness by spectroscopy (Table 1). When using 640/30 
nm light, mCardinal was uniquely brighter than all other far-red FPs (Fig. 3b), consistent with its 
predicted advantage at these redder excitation wavelengths (Table 1). We also compared 
mCardinal with iRFP, a bacteriophytochrome mutant that binds biliverdin to enhance its infrared 
fluorescence, for the ability to detect gene expression in the liver following hydrodynamic 
injection of plasmid DNA. Compared to iRFP excited at 675/30 nm, mCardinal yielded a higher 
signal/background ratio with 605/30 nm excitation and a similar signal/background ratio with 
640/30 nm excitation (Supplementary Fig. 12). In preparation for µm-resolution imaging in 
mouse tissues, we equipped a fluorescence stereoscope using 620/20 nm excitation filters, 
selected so that all excitation wavelengths are beyond 600 nm while still efficiently exciting far-
red FPs. In this system, mCardinal again yielded the highest brightness among the mNeptune 
derivatives (Fig. 3c). Thus, mCardinal performs especially well in deep-tissue imaging with 
wavelengths of light above 600 nm.  
 Stem cell therapy for repairing damaged or degenerated muscles is an area of active 
research. Stem cell performance varies with implantation timing and dosage, as well as cell source 
and growth conditions ex vivo and in vivo17. Stem cell research could thus benefit from a reliable 
method for visualizing muscle differentiation non-invasively and with high anatomical detail18. 
We tested the ability of mCardinal to track the fate of myoblasts in injured tibialis anterior (TA) 
muscle in living mice, a widely used model for cellular therapy for muscle degenerative 
diseases19. We created myoblasts stably expressing mCardinal, then injected them into TA 
muscles injured with notexin to induce muscle fiber degeneration19. We then imaged the legs 
over many weeks using 620/20 nm light (Fig. 4a-c). Injected cells were visible by mCardinal 
fluorescence immediately after injection then declined in the first 7 days post-injection (d.p.i.), 
consistent with previous studies using bioluminescence19. Beginning at 3 d.p.i., thin mCardinal-
positive fibers appeared in the leg, gradually increasing in number over the next 46 days and then 
reaching steady state. Multiple rounds of fluorescence imaging of the same area showed that 
mCardinal was photostable in vivo (Supplementary Fig. 13). We also tested the ability of 
mCardinal to image pluripotent muscle stem cells. We injected 1000 stem cells transduced with a 
mCardinal- and luciferase-expressing lentivirus into TA muscles of SCID mice that had been 
injured with notexin and 18-Gy irradiation, which enhances engraftment of injected stem cells by 
incapacitating endogenous myogenic cells19. At 30 d.p.i., notexin was injected again to further 
expand muscle stem cells, as previously observed19. Strong fluorescence signal was subsequently 
observed with the morphology of differentiated myofibers throughout a large region of the TA 
muscle (Fig. 4d,e). Contrast over background from a 1-min exposure was 11 (calculated as the 
ratio of fluorescence intensity from fibers to autofluorescence intensity from a non-injected leg). 
Bioluminescence can achieve higher detection sensitivity than fluorescence in animals due to 
negligible background20; thus we also tested the ability to visualize myofibers derived from stem 
cells using bioluminescence imaging of luciferase. An 8-min acquisition of bioluminescence 
signal at a similar pixel sampling resolution (21 µm/pixel vs. 15 for fluorescence) showed only a 
diffuse signal without structural features (Fig. 4f,g). Thus, fluorescence imaging with mCardinal 
allows visualization of differentiation and incorporation of stem cell derivatives in situ in living 
animals with superior detail compared to bioluminescence. 
 We next assessed whether mCardinal improves non-invasive imaging of myocytes in vivo 
compared to mNeptune1, iRFP, or Clover, currently the brightest GFP derivative21. We created 
stable myoblast cell lines coexpressing mCardinal or mNeptune1 with iRFP (Supplementary Fig. 
14), injected them into injured TA muscle, then imaged 56 days later with optimized filters 
(Supplementary Fig. 15). Far-red fluorescence from cells expressing mNeptune1 was dimmer 
than from cells expressing mCardinal (Fig. 5a). Unexpectedly, with cells coexpressing iRFP and 
mCardinal, only extremely faint infrared fluorescence from iRFP was visible upon excitation at 
680-700 nm light, while far-red fluorescence from mCardinal was easily detectable (Fig. 5a), 
suggesting that differentiated myocytes may maintain low levels of biliverdin. Intraperitoneal 
administration of biliverdin did not improve iRFP signal (Fig. 5b), suggesting that myocytes may 
not take up circulating biliverdin efficiently. We then compared the ability of mCardinal and 
Clover to image myocyte differentiation in vivo by stably transfecting stem cells with mCardinal 
and Clover (Supplementary Fig. 16), followed by injection into injured TA muscle. In the green 
channel, we only observed muscle autofluorescence interrupted by blood vessels, as expected 
from the absorption of blue and green light by hemoglobin, while mCardinal again gave clear 
signals (Fig. 5c). These results demonstrate that fluorescence imaging of mCardinal with red 
excitation light improves non-invasive visualization of cellular differentiation in deep tissues. 
 
DISCUSSION 
 In fluorescence imaging, the limiting factor in detection is the ratio of specific signal to 
background autofluorescence, so the concentration and molar brightness of a FP must be 
sufficiently high to create a signal over background20. Once that condition is achieved, however, 
shorter integration times are possible with FPs than with luciferase. FPs are capable of emission 
rates of millions of photons per second per molecule22, orders of magnitude more than the 2.7 
photons per second of peak luciferase emission23. In macroscopic applications, illumination 
intensity is a limiting factor in determining exposure time for fluorescence detection. Using light 
from an inexpensive 32-W light-emitting diode source passing through a low-numerical aperture 
lens of a standard variable-magnification dissecting microscope, we were able to image 
myocytes non-invasively with acquisition times as short as 5 s. These imaging times allow 
repositioning of the mouse and multiple acquisitions in one session, something not possible with 
bioluminescence because luciferase signal will decay appreciably over the minutes-long time 
frame of a single exposure24. We expect that use of higher-power light sources, higher-numerical 
aperture optics, and stereoscopes optimized for light capture and transmission can reduce 
acquisition times further to the sub-second range. 
 Bioluminescence and fluorescence can have complementary roles in tracking cellular 
differentiation. The greater detection sensitivity of bioluminescence is useful for detecting low 
numbers of cells, discerning general trends in cell number and location, and screening multiple 
animals in wide fields of view25. Non-invasive fluorescence imaging with mCardinal can be used 
to study specific interesting regions at higher magnification, either once or over time to assess 
how experimental conditions influence their survival or differentiation. In addition to its use in 
animals, mCardinal should be the FP of choice in microscopy when excitation with 633-635 nm 
lasers is needed, either for multi-wavelength imaging or to avoid autofluorescence from 
endogenous compounds3. In particular, mCardinal should improve fluorescence imaging of cells 
such as hepatocytes, neurons, or retinal pigment epithelial cells that contain high levels of 
lipofuscin, which is excited efficiently by all visible wavelengths below 620 nm26-28. As a 
traditional autocatalytic fluorescent protein, mCardinal may provide advantages over 
phytochrome-biliverdin fluorescent complexes in cells where biliverdin concentrations are low. 
In summary, with its unique combination of brightness, excitability with red light, and cofactor-
independence, mCardinal should be useful in a wide variety of in vivo imaging applications. 
 
  
Accession codes. GenBank accession codes are KJ131553 (mNeptune2), KJ131554 
(mNeptune2.5), and KJ131552 (mCardinal). Mammalian expression plasmids are available at 
Addgene with identification numbers 51309 (mNeptune2), 51310 (mNeptune2.5), and 51311 
(mCardinal). PDB accession codes are mCardinal (XXXX) and mCardinal-V218E (4OJ0). 
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FIGURE LEGENDS 
 
Figure 1. Spectral characteristics of new far-red FPs. (a) Absorbance spectra of oxygenated 
hemoglobin (oxyHb), deoxygenated hemoglobin (deoxyHb), and monomeric far-red FPs. 
Myoglobin spectra are similar to hemoglobin spectra29. (b) Normalized excitation (left) and 
emission (right) spectra of monomeric far-red FPs. (c) Transmittance of mKate2, mNeptune1, 
mNeptune2, mNeptune2.5, mCardinal, and TagRFP657 at 1 mg/mL of purified mature protein. 
Blue transmission of mCardinal is due to efficient absorbance of green and red light.  
 
Figure 2. Structural basis of red-shifting in mCardinal. (a) Structure of Neptune showing the 
water molecule hydrogen-bonded to the acylimine oxygen of the chromophore. The fluorescent 
protein is viewed down the axis of the beta-barrel from the direction of the N- and C-termini. 
Beta-strands and alpha-helices are depicted in cartoon form. The chromophore, the Met63 side 
chain attached to the chromophore, and the water are depicted in stick representation with carbon 
colored lavender, nitrogen blue, and oxygen red. Numbers indicate distances between the water 
oxygen atom and hydrogen-bonding partners. Cyan labels indicate positions mutated to amino 
acids with side chains capable of donating hydrogen bonds to the acylimine oxygen: Met11, 
Leu13, Ser28 and Gly41. (b,c) Hydrogen bond interactions between Thr28, Gln41, and the 
chromophore acylimine in mCardinal (b) or mCardinal-V218E (c). Rendering is of chain A. 
Distances shown are averages of measurements from chains with temperature factors for Gln41 
amide atoms lower than those for the hydrogen-bonding water molecule in the Neptune structure, 
specifically chains A and B for mCardinal and chains A and C for mCardinal-V218E. Mesh 
depicts electron density in the Fo-Fc OMIT map contoured to 3.0 sigma within 2.0 Å of the 
atoms displayed in stick form. 
 
Figure 3. Comparison of far-red FPs for deep-tissue imaging. (a,b,c) Left, representative 
fluorescence images of equal amounts of purified far-red FPs placed within the esophagus of 
euthanized mice. Images were acquired with 605/30 nm excitation in an IVIS Spectrum (a), 
640/30 nm excitation in an IVIS spectrum (b), or with 620/20 nm excitation on a SZX-12 
fluorescence stereomicroscope (c). Pseudocolor scale represents signal-to-background ratio, 
calculated as (FFP – FPBS) / FPBS, where FFP and FPBS were total intensities measured in a common 
region of interest encompassing all fluorescence signal in images of FP and PBS, respectively. 
Scale bars, 1 cm. Right, quantification of signal-to-background ratio and signal intensity 
subtracted by background in units of 108 photons per second per steradian (p s–1 sr–1 µW–1 × 108) 
presented as mean ± standard error of the mean (SEM), n = 4 for (a,b) and 5 for (c). Differences 
are statistically significant by one-way ANOVA (P < 0.0001). Asterisks indicate significant 
differences by Dunnett’s multiple comparison test versus mNeptune1 (*P < 0.05, **P < 0.01, 
***P < 0.001, and ****P < 0.0001). 
 
Figure 4. Non-invasive longitudinal visualization of muscle regeneration in living mice. (a) 
Tibialis anterior (TA) muscles injected with 1 million myoblasts expressing mCardinal, imaged 
with a fluorescence stereoscope with 620/20 nm excitation. All images are normalized to the 
same intensity scale. Series is representative of 5 repeats. (b) Images from 3, 7, and 14 days post-
injection (d.p.i.) are shown with intensity scaling tighter than in (a) by a factor of 10, 10, and 5 
respectively. (c) Magnified view of the muscle at 7 d.p.i., showing an early regenerating fiber 
(arrow). The image at right is deliberately enlarged until pixelated to show that this fiber appears 
just a few pixels wide. (d) Fluorescence signal from TA muscles injected with 1000 muscle stem 
cells expressing mCardinal. (e) Magnified view of the muscle at 44 d.p.i., showing multiple 
regenerating fibers (arrows). (f) Bioluminescence imaging at 42 d.p.i. of stem cells shown in (d). 
A single 8-min bioluminescence image was acquired at the highest possible resolution with no 
binning. The resulting sampling resolution (21 μm/pixel) is similar to that (15 μm/pixel) of the 
fluorescence images in (e). (g) Enlargement of the luminescence image in (f) shows the absence 
of structures resembling myofibers. The right panel is enlarged to show the presence of noise at 
the level of individual pixels. In a 40-pixel × 30-pixel region containing the brightest pixels, 
standard deviation was 33 while mean intensity was 290 counts over that of a background region, 
indicating presence of substantial shot and read noise relative to signal.  
 
Figure 5. Comparison of mCardinal with mNeptune1, iRFP and Clover GFP for non-invasive 
visualization of muscle regeneration in living mice. (a) Representative fluorescence images of 
tibialis anterior (TA) muscles injected with 1 million myoblasts expressing iRFP and mCardinal 
or iRFP and mNeptune1. Images were taken in the absence of exogenous biliverdin. The bar 
graph shows contrast over background (mean ± SEM, n = 6 and n = 8 for mNeptune1 and 
mCardinal, respectively). Asterisks indicate significant differences by unpaired two-tailed 
Student t test (* P < 0.05 and *** P < 0.001). (b) Representative fluorescence images of TA 
muscles expressing mCardinal and iRFP in the absence (top panel) and presence (middle panel) 
of 250 nM biliverdin. The leg injected with untransfected myoblasts (bottom panel) was used as 
a negative control. (c) Representative fluorescence images of TA muscles injected with 5000 
muscle stem cells expressing Clover and mCardinal at 29 d.p.i. The white arrow indicates 
mCardinal-positive muscle fibers. Shadows of blood vessels (highlighted in the inset) are 
expected from absorption of green autofluorescence by blood. 
  
TABLE  
 
Table 1. Characteristics of far-red and infrared FPs  
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Excitation peak (nm) 587 588 600 599 599 604 611 605 592 605 684 690 
Emission peak (nm) 610 630 651 651 643 659 659 646 650 670 707 713 
ε at peak (mM-1cm-1)a 72 50 75 89 95 87 29 59 65 70 102 105 
φ totalb 0.22 0.40j 0.23 0.24 0.28 0.19 0.10 0.12 0.24 0.060 0.070 0.059
BR excited at peakc 16 20 17 21 27 17 2.9 7.1 16 4.2 7.1 6.2 
ε at 635 nm (mM-1cm-1) 0.62 1.4 9.6 12 11 18 13 19 5.9 20 55 52 
φ > 635 nm 0.09
4 
0.25 0.18 0.19 0.20 0.16 0.09 0.10 0.18 0.055 0.070 0.059
BR excited at 635 nmd 0.05
8 
0.35 1.9 2.2 2.2 2.8 1.2 1.9 1.1 1.1 3.9 3.1 
Maturation half-time 
(min)e 
40 38 28 27 26 27 88 24  ND ND 114 168 
Maturation efficiencyf ND 0.52 0.48 0.53 0.52 0.60 0.66 ND ND ND ND ND 
Photostability (s)g 68 81 (84j) 160 373 506 730 110 ND ND ND ND ND 
pKa <4.5 6.5 5.4 6.3 5.8 5.3 5.1 4.5 5.7 4.5 4.6 4.0 
quaternary structure  
(m = monomer, d = 
dimer) 
m 
 
m m m m m m d d d m d 
Red/green 
fluorescence ratiol 
ND 4.1 2.4 5.6 8.2 5.8 0.47 ND ND ND ND ND 
aε = extinction coefficient, measured as in ref. 30. 
bφ = quantum yield. 
cCalculated as the product of ε at peak excitation and φ in units of mM-1cm-1. 
dCalculated as the product of ε at 635 nm, emission fraction above 635 nm, and φ in units of mM-1cm-1. 
eTime for fluorescence to obtain half-maximal value after exposure to oxygen. 
fFunctional chromophore concentration divided by total protein concentration. 
gPredicted time for fluorescence to photobleach by 50% under arc lamp illumination with excitation intensity adjusted 
to produce 1000 emission photons per molecule per s. 
hData from ref. 7. 
iData from ref. 14. 
jData from ref. 13. 
kData from ref. 19. 
lRatio of far-red emission peak to green emission peak when excited by 490-510 nm light. 
  
ONLINE METHODS 
 
Mutagenesis and screening of libraries. Mutations at specific residues were introduced by 
overlap-extension PCR. All PCR products were cut and ligated into a constitutive bacterial 
expression vector pNCS (Allele Biotech) or arabinose-inducible pBAD (Invitrogen). For all 
library construction methods, chemically competent Escherichia coli strain DH5α (BioExpress) 
or XL-10 Gold (Invitrogen) were transformed and grown overnight on LB/agar at 37°C and 
maintained thereafter at room temperature. For each round of mutagenesis, a number of colonies 
approximately 10-fold higher than the expected library diversity were screened to ensure full 
coverage. Agar plates were screened for transmitted color by eye and for fluorescence in a light-
tight enclosure with a KL2500 fiberoptic light source (Leica) and a ST-8300M cooled CCD 
camera controlled with CCDOps software (Santa Barbara Instrument Group) on a MacBook Pro 
running OS 10.6.8 (Apple). 610/20 nm excitation and 645/30 nm emission filters (Chroma) were 
placed in the light path before the fiberoptic light guide and before the camera, respectively. 
Bacterial colonies of interest were patched on LB/agar plates and incubated overnight at 37°C. 
Lysates were extracted with B-PER II (Pierce), and spectra were obtained on a Safire II plate 
reader (TECAN). DNA sequences of all constructs are available upon request. 
 
Protein production and characterization. Fluorescent proteins with polyhistidine tags were 
expressed from pNCS vectors in E. coli strain DH5α, purified with cobalt-chelating affinity 
chromatography (Pierce) and desalted using gel filtration columns (Bio-rad). Excitation and 
emission spectra of recombinant proteins were measured with a Horiba Jobin Yvon Fluorolog 3 
fluorimeter (HORIBA Scientific). Absorbance spectra were obtained on a SafireII plate reader 
(Tecan). Extinction coefficients were calculated using the base-denaturation method, as 
previously described for red fluorescent proteins30. Quantum yields were determined by 
integration of emission curves corrected for detector sensitivity, using mKate2 as a standard 
(quantum yield 0.4). pH titrations were performed using a series of buffers (1 M HOAc, 1 M 
NaOAc, 5 M NaCl for pH 3.0-4.5; 1 M NaH2PO4, 1 M Na2HPO4, 5 M NaCl for pH 5-9.0; 100 
mM glycine for pH 9.5 and 10). 5 μL of purified protein was diluted in 145 μL buffer with 
different pH values and the fluorescence brightness was measured. 
 For maturation experiments, bacteria of E. coli strain TOP10 transformed with pBAD 
vectors expressing FPs were grown at 37°C in sealed 2 mL tubes filled up with 2.2 mL LB media 
deoxygenated by bubbling with CO2 gas and supplemented with 4% D-glucose. After 24 h, the 
culture was spun down, resuspended in supplemented LB media containing 100 µg/mL 
ampicillin and 0.1% L-arabinose, and cultured for another 3 hours at 30°C in aerobic conditions. 
Bacteria were then quickly lysed with B-PER II (Pierce) in aerobic conditions and fluorescence 
of lysates measured as a function of time on the Safire II plate reader.  
 For semi-native PAGE, 10 μg of purified proteins were loaded without boiling onto 4%–
12% Bis-Tris polyacrylamide gels (Invitrogen) and electrophoresed in MOPS electrophoresis 
buffer. Gels were imaged for fluorescence with 400-500 nm excitation light and a yellow acrylic 
longpass filter in a BlueView Transilluminator (Vernier).  
 In vitro photobleaching measurements were performed in aqueous droplets of purified 
proteins in oil using a Zeiss Axiovert 200M inverted microscope with a 40× 1.2-numerical 
aperture (NA) water immersion objective (Zeiss), an X-Cite 120-W metal halide lamp (Lumen 
Dynamics), and a 615/20 nm excitation filter (Chroma). The microscope was operated with 
Micro-Manager 1.4.2 in MacOS 10.6.8 on a 2.5-GHz Core 2 Duo MacBook Pro computer 
(Apple). Images were taken every 1 s under continuous illumination. Times were adjusted to 
produce photon output rates of 1000 per molecule per s as described previously31.  
 
Crystallization and structure determination of mCardinal. Polyhistidine-mCardinal was 
purified from bacterial lysates with metal affinity resin, then the polyhistidine tag was removed 
with EKMax Enterokinase and EK-Away Resin (Invitrogen) and the buffer was changed to 20 
mM Tris, 20 mM HCl pH 8. The protein was then lysine-methylated and repurified into HEPES-
buffered saline pH 7.3 as previously described32. Absorption, excitation, and emission spectra 
confirmed that lysine-methylation did not affect mCardinal spectral properties. mCardinal was 
crystallized by the hanging-drop vapor diffusion method by mixing equal volumes of 10 mg/mL 
protein with of 0.2 M calcium chloride, 10 mM Tris(2-carboxyethyl)phosphine HCl, 0.1 M Tris 
HCl pH 7.6, and 22-25% PEG 4000. Crystals were cryoprotected in well solution supplemented 
with 15% ethylene glycol and flash cooled in liquid nitrogen. Diffraction data were collected at 
beamline 8.2.2 at the Advanced Light Source (Berkeley, US). A 2.2 Å dataset was obtained and 
processed with XDS33. The structure of mCardinal was solved by molecular replacement using 
PHASER34 with the structure of Neptune (PDB accession number 3IP2) as the search model. 
Analysis of the data with PHENIX35 indicated a spacegroup of P2(1) with pseudomerohedral 
twinning and a refined twin factor of 0.50. Refinement was conducted with PHENIX using least-
square twin refinement with twin law h, –k, –l. The model was edited with COOT36. Initial 
refinement used rigid body, coordinate, and real space refinement with individual atomic 
displacement parameter refinement and non-crystallography symmetry (NCS) restraints. NCS 
restraints were omitted in subsequent rounds of refinement, and translation/libration/screw (TLS) 
refinement was added. The Fo-Fc OMIT map was calculated with PHENIX using the averaged 
kick approach to minimize model bias37. The OMIT map was contoured to 3.0 sigma with a –30 
Å2 temperature factor sharpening factor38. 
  After purification and tag removal as above, mCardinal-V218E was exchanged into 50 
mM Tris (hydroxymethyl)aminomethane, 25 mM NaCl, 4.0 mM TCEP at pH 7.5, then 
concentrated to 10 mg/mL using an Amicon ultra 10 kDa-cutoff centrifugal unit (Millipore). The 
protein was mixed in 3:1 ratio with 0.2 M calcium acetate, 0.1 M MES:NaOH pH 6.0, and 20% 
(w/v) PEG 8000 (condition B6 from MSCG-1 crystallization condition set, Microlytic), then 
allowed to crystallize for 3 d at 12ºC in the dark. The crystals were washed for 20 s in paratone 
oil for cryoprotection before they were mounted on a MicroLoop (MiTeGen), cryo-cooled in 
liquid nitrogen, and loaded for remote collection at beamline 12.3.1 at the Advanced Light 
Source. Diffraction data were processed with XDS. The structure  was solved by molecular 
replacement using MOLREP39 with the structure of Neptune (PDB accession number 3IP2) as 
the search model. PHENIX was used to automatically build > 95% of the structure. The structure 
was refined with REFMAC40 and PHENIX using TLS parameters, alternating with manual 
correction of the model using COOT.  
 Chains where temperature factors for the Gln41 amide atoms were lower than that of the 
water oxygen in Neptune (36.9) were used to measure distances between the Gln41 amide and 
the chromophore acylimine groups and between the Gln41 amide and Thr28 hydroxyl groups. 
 
Fusion gene construction. mCardinal cDNA was PCR amplified with a 5’ primer encoding an 
AgeI site and a 3’ primer encoding either a BspEI (C1) or NotI (N1) site for C-terminal and N-
terminal fusions (with regards to the FP), respectively. The purified and digested PCR products 
were ligated into similarly digested pEGFP-C1 and pEGFP-N1 cloning vectors to create 
pmCardinal-C1 and pmCardinal-N1. A cDNA fragment encoding each protein domain was PCR 
amplified with primers containing the appropriate restriction enzyme sites and ligated into 
pmCardinal-C1 or pmCardinal-N1. To prepare fusions at the N-terminus of mCardinal, the 
following digests were performed: human non-muscle α-actinin (GenBank accession number 
NM_001130005.1, source: Tom Keller, Florida State University, Tallahassee, FL, U.S.A.), 
EcoRI and NotI; human calnexin (NM_001746.3, Origene), AgeI and NotI; human centromere 
protein B (NM_001810.5, Alexey Khodjakov, Wadsworth Center, Albany, NY, U.S.A.), BamHI 
and NotI; rat β-2 connexin-26 (NM_001004099.1, Matthias Falk, Lehigh University, Bethlehem, 
PA, U.S.A.), EcoRI and BamHI; human keratin 18 (NM_199187.1, Open Biosystems), EcoRI 
and NotI; yeast Lifeact (IDT DNA), BamHI and NotI; human pyruvate dehydrogenase, 
(NM_000284, Origene), AgeI and NotI; human peroxisomal membrane protein (NM_018663.1, 
Origene), NotI and AgeI; human vimentin (NM_003380.3, Origene), NheI and BamHI; chicken 
paxillin (NM_204984.1, Clare Waterman, NIH, Bethesda, MD, U.S.A), NheI and BamHI; mouse 
mannosidase II (NM_008549.2, Jennifer Lippincott-Schwartz, NIH), NheI and BamHI; and 
human histone H1 (NM_008197.3, David Gilbert, Florida State University), BamHI and NheI. 
To prepare C-terminal fusions to mCardinal, the following digests were performed: human β-
actin (NM_001101.3, Clontech), NheI and BglII; human α-tubulin (NM_006082, Clontech), 
NheI and BglII; human Rab4a (NM_004578.2, Viki Allen, University of Manchester, U.K.), 
BspEI and BamHI; human lamin B1 (NM_005573.2, George Patterson, NIH), EcoRI and BamHI; 
human myotilin (NM_006790.1, Origene), AgeI and BspEI; human fibrillarin (NM_001436.3, 
Evrogen), BglII and BamHI; human tight junction protein ZO1 (NM_003257.1, Origene), AgeI 
and BspEI; human VE cadherin (NM_001795.3, Origene), BglII and EcoRI; and the 20-amino-
acid farnesylation signal from c-Ha-Ras (NM_001130442.1, Clontech), AgeI and BspEI. Full 
sequences of plasmids are available upon request. 
 
Fluorescence Microscopy. HeLa cells (CCL-2 and S-3, ATCC) were grown in a 50:50 mixture 
of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium (Sigma-Aldrich) 
with 15% calf serum (HyClone). NIH 3T3 cells were grown in DMEM with 10% fetal bovine 
serum (FBS, HyClone). FoLu cells were grown in Eagle’s minimal essential medium with 
Earle’s balanced salt solution, 1% non-essential amino acids (Sigma-Aldrich), and 10% FBS 
(HyClone). Cells were transfected with Effectene (Qiagen). Imaging was performed in Delta-T 
culture chambers (Bioptechs) under a humidified atmosphere of 5% CO2 in air. Single-image 
microscopy of fusion proteins was performed using either a Nikon Eclipse 80i equipped with a 
Chroma Cy5 filter set (Ex = 620/60 nm; Em = 700/75 nm; DM = 660 nm LP) or a Zeiss Axiovert 
equipped with a Semrock Cy5 filter set (Ex = 628/40 nm; Em = 700/75 nm; DM = 660 nm LP). 
Time-lapse microscopy was performed using an IX81 inverted microscope with a FV1000 
confocal scanning unit, a PlanApo 60× 1.4 NA oil objective, a 633 nm helium-neon laser, and a 
manufacturer-installed Cy5 emission filter (Olympus). For time-lapse imaging of mCardinal-
18aa-β-actin, the following settings were used: 2.2× zoom, 12.5 µs pixel dwell time, 400 µm 
pinhole, 2× Kallman filtering per line, 680 V photomultiplier tube voltage, 645-745 nm emission 
filter, 18 s interframe interval. For time-lapse imaging of PDHA1-10aa-mCardinal, the following 
settings were used: 2.2× zoom, 10 µs pixel dwell time, 400 µm pinhole, 2× Kalman filtering per 
line, 650 V photomultiplier tube voltage, 645–745 nm emission filter, 15 s interframe interval.  
 Live-cell photobleaching was performed in live HeLa S3 cells expressing far-red FPs 
fused to human histone H2B under arc lamp and laser illumination. Arc-lamp photobleaching 
was performed on a TE2000 inverted microscope with a Plan Fluorite 40× 0.85-NA dry 
objective (Nikon), an X-Cite Exacte 120-W metal halide lamp (Lumen Dynamics), and a 
Brightline Cy5-4040C-000 filter cube (excitation 628/40 nm; dichroic mirror 660 nm, emission 
692/40 nm, Semrock). A 1918-C optical power meter (Newport) measured illumination power at 
the objective as 19.7 mW. Power moderation was achieved by using neutral density filters 
contained within the lamp. With a 3.125% neutral density (ND32) filter in place, several regions 
containing at least 30 nuclei in total were located. The neutral density filter was then removed 
and the region was photobleached continuously while imaged with a Q-Imaging Retiga EXi 
camera (Photometrics) with 200-ms exposure times for 6 min for a total of 3100 frames. The raw 
data was collected using NIS-Elements software (Nikon) and then analyzed with Simple PCI 
software (Hamamatsu). Laser photobleaching measurements were collected on a FV1000 
confocal microscope with a PLAPO 40× 1.0-NA oil-immersion objective (Olympus) and a 543-
nm He-Ne laser (Melles Griot) tuned to an output power of 1005 µW, as measured at the 
objective with a FieldMax II-TO power meter (Coherent). Scan settings were 2× zoom, 600 µm 
pinhole size, 515 V photomultiplier voltage, 4 µs pixel dwell time. Emission was collected with 
detector slit settings of 600-700 nm. Several regions containing at least 30 nuclei in total were 
first located with minimal laser power. The laser power was raised back to 1005 µW and each 
region was photobleached continuously for ~20 min for a total of 1500 frames. Raw data was 
collected with the FluoView software (Olympus) and then analyzed with Simple PCI software.  
 For luciferase-normalized fluorescence intensity measurements, HeLa cells (4 × 106) 
were lysed in 600 µL of pH 7.2 luciferase reporter buffer (Promega) containing protease 
inhibitor cocktail (Roche). Fluorescence spectra with three different excitation wavelengths were 
taken in a 96-well plate in a volume of 150 μL on a plate reader Safire II (Tecan) with corrected 
excitation and emission. Fluorescence intensities were calculated by integrating the area of the 
emission spectrum between 660 nm and 800 nm. Bioluminescence measurements were 
performed in a 96-well plate in a volume of 60 μL (10 μL of lysate and 50 μL of luciferin 
substrate) on a Veritas microplate luminometer with injectors (Turner Biosystems). 
 
Worm culture and imaging. C. elegans worms were maintained at 20°C on OP50 E. coli-
seeded nematode growth medium plates. Transgenic strains were made by micro-injection of 
plasmid DNA into the gonads of adult hermaphrodites as previously described41. Transgenic line 
TV13901 (wyEx5674; wyIs251) was generated by injecting a mixture of 10 ng/µL Pmig-
13::SNG-1::mCardinal, 5 ng/µL Pmyo-3::DsRed, and 25 ng/µL Podr-1::mRFP into wyIs251 
(Pmig-13::GFP::Rab-3) worms. Line TV13928 (wyEx5684; vsIs147; syIs65) was generated by 
injecting a mixture of 10 ng/µL Pegl-17::mCardinal and 25 ng/µL Podr-1::DsRed into vsIs147 
(Punc-103e::mCD8::mCherry); syIs65 (B0034.1::pes-10::GFP) worms. Line TV14404 
(wyEx5836) was generated by injecting a mixture of 15 ng/µL Pmyo-2::mCardinal and 25 ng/µL 
Podr-1::GFP into N2 strain worms. Mixtures were injected at a volume sufficient to visualize 
gonad filling without causing damage. Podr-1::GFP labels AWC neurons as a positive control.  
Three-color imaging was performed in live C. elegans using high NA objectives (40× 
1.20-NA water objective for presynaptic vesicles and 100× 1.40-NA oil objective for vulva) on 
an Axiovert 200M inverted fluorescence microscope (Zeiss). Worms were transferred onto a 
hydrated 2% agarose pad in M9 solution and immobilized using a mixture of 200 mM 2,3-
butanedione monoxime (Sigma-Aldrich, St Louis, MO) and 2.5 mM levamisole (Sigma-Aldrich) 
in 10 mM Na-HEPES. Fluorescence images were acquired consecutively under three channels: 
green channel (ex-470/30 nm, DM-510LP nm and em-530/40 nm) for GFP, red channel (ex-
545/10 nm, DM-570LP nm and em-590/45 nm) for DsRed or mCherry, and far-red channel (ex-
615/30 nm, DM-630LP nm and em-675/50 nm) for mCardinal. Fast time-lapse imaging of freely 
moving worms or pharyngeal muscle contraction was performed on the FV1000 microscope with 
a 20× 0.75-NA objective. Worms were transferred onto a hydrated 2% agarose pad in M9 
solution with or without the treatment of cyanoacrylate glue, which can partially immobilize the 
worms. 1 mg/mL serotonin (Sigma-Aldrich) in M9 was added to induce pharyngeal pumping in 
partially immobilized worms42. Time-series scans, with 256×256 pixels/frame resolution (0.414 
μm/pixel), were taken in roundtrip scanning mode with a pixel dwell time of 0.5 μs thereby 
achieving a frame rate at 125 ms/frame sufficient to resolve free movement and pharyngeal 
pumping events. A red diode laser was used for excitation (635 nm, 50% power) and emission 
between 650 nm and 750 nm was collected. 
 
Deep-tissue imaging in euthanized mice. All procedures with mice (esophagus, liver and stem 
cell imaging) were conducted in accordance with NIH regulations and approved by the Stanford 
Institutional Animal Care and Use Committee. The minimum number of mice used in this study 
was calculated as described43. All mice were grouped according to body weight on the day of 
injection. 10-week-old male nude mice (strain NU/NU) were obtained from the Charles River 
Laboratories. Mice were fed low-fluorescence purified diet (TD.97184, Harlan) for 1 week. 
Purified FPs were diluted in PBS to 60 μM, then 4 μL of FPs or PBS was loaded into small glass 
capillary tubes with 0.8-1.1 mm inner diameter (Kimble Chase, Cat# 34507-99) and centrifuged 
to the bottom of the tubes at 3000 rpm for 5 min. A mouse was euthanized by an overdose of 
isoflurane anesthesia, then background fluorescence was allowed to stabilize for 20 min after 
death, and then the mouse was immobilized for tube placement and imaging. Imaging was 
performed with an IVIS Spectrum system (Perkin Elmer) with a DW436 back-thinned CCD with 
2048×2048 13.5-μm pixels and 95% peak quantum efficiency (Andor), or an SZX12 
fluorescence stereoscope with a 1× 0.11-NA PlanApo objective (Olympus), a 35-W 615-nm 
LED (CoolLED), a 620/20-nm excitation filter, a 667/30-nm emission filter, and a Retiga 
4000RV cooled CCD digital camera (QImaging). IVIS Spectrum settings were: field of view 13 
cm, aperture f/1, binning 4×4, and exposure time 5 s (605/30 nm excitation) or 10 s (640/30 nm 
excitation). SZX12 settings were: zoom 7×, binning 2×2, and exposure time 10 s. Each tube in 
the series was inserted into the esophagus of the same mouse to the same location and imaged, 
and then the entire set was repeated 4 more times. Quantitative measurements of fluorescence 
signal (presented as signal/background ratio) were made with Living Image Software 4.3.1 and 
ImageJ 1.46r. For each FP, a signal-to-background ratio in each channel was calculated as (FFP – 
FPBS) / FPBS, where FFP and FPBS were total intensities measured in a common region of interest 
encompassing all fluorescence signal from the images of the FP and PBS, respectively. 
 
Liver transfection and imaging in living mice. 6~7 week-old male nude mice of strain 
J:NU(007850) were obtained from the Jackson Laboratory and fed with low-fluorescence 
purified diet (TD.97184, Harlan) for a week. Using a hydrodynamic injection protocol, 20 μg of 
plasmid DNA in 1.8 mL of saline (0.9% NaCl) was injected into the tail vein of the mice within 
5-6 seconds. Fluorescence imaging was performed 40 h after injection on the IVIS Spectrum 
with exposure time 60 s, binning 2×2, aperture f/1, and field of view 22.4 cm. mCardinal was 
imaged with 605/30 nm excitation and 660/20 nm emission, or 640/30 nm excitation and 700/20 
nm emission. iRFP was imaged with 675/30 excitation and 740/20 nm emission. Data analysis 
was performed as with deep-tissue imaging in euthanized mice above. 
 
Muscle cell transfection and in vivo imaging of muscle cell regeneration. Primary myoblasts 
and muscle stem cells (MuSCs) were isolated from mice. Briefly, forelimbs and hindlimbs were 
removed from 8-week-old mice (strain C57/BL6) and bones removed. The muscles were 
transferred to F10 media and minced into a slurry with razor blades. Muscles were enzymatically 
dissociated by the addition of 2 mL per g of tissue of a solution of dispase and collagenase. The 
slurry was maintained at 37°C for 30-45 minutes while triturated every 15 minutes with a 5-mL 
plastic pipette, then passed through 80 µm nylon. The filtrate was spun at 350× g0 to sediment 
the dissociated cells, the pellet was resuspended in growth medium, and the suspension was 
plated on collagen-coated dishes. During the first several passages of the primary cultures, 
myoblasts were enriched by preplating. Muscle stem cells were prepared by enzymatic digestion 
of muscle sample, stained with biotin-labeled antibodies (CD45, CD31, CD11b, and Sca1) for 
magnetic depletion of non-myogenic cells and then with specific antibodies (CD34 and α7-
integrin) for myogenic markers. Cells were then purified by two rounds of cell sorting for the 
(CD45/CD11b/CD31/Sca1)-negative CD34-positive α7-integrin-positive cell population as 
previously described19. 
 Constructs expressed in myoblasts were pCMV-piggyBac, MCm-CMV-mCardinal, 
MCm-CMV-iRFP-P2A-mCardinal, and MCm-CMV-iRFP-P2A-mNeptune1. MCm plasmids are 
modified minicircle plasmids with piggyBac long terminal repeats. Lentiviral constructs 
expressed in MuSCs were hLIG-EF1α-mCardinal-IRESPV-luciferase2 and pLL3.7-EF1α-
mCardinal-IRESEMCV-Clover-P2A-luciferase2. Full sequences of plasmids are available upon 
request. One million myoblasts were transfected with 5.3 μg total of minicircle vector and 
pCMV-piggyBac in a 3:1 molar ratio in Solution V from the Cell Line Optimization 
Nucleofector Kit (Lonza) with program B-32 on a Nucleofector I electroporation machine 
(Lonza). Myoblasts were cultured for 10 days, and then the 10% of cells exhibiting the highest 
far-red fluorescence upon 635 nm excitation were selected by fluorescence activated cell sorting 
on a FACSAria II (Becton-Dickinson). Myoblasts were further cultured for 7 days, and then 
injected in injured TA muscles. For MuSC infection, plates were coated with 20 µg/mL 
retronectin in PBS for 2 h at room temperature, then with 200 μL 2% bovine serum albumim in 
PBS for 30 min, then washed with PBS. MuSCs and lentivirus were mixed in a 1:10 ratio in 
media with 5 µg/mL protamine sulfate, then plated and incubated overnight at 37°C. The next 
day, MuSCs were harvested and injected in injured TA muscles.  
 All images of muscles were acquired non-invasively on living mice. TA muscles of 4-
week-old male mice (SCID Congenic, Charles River Laboratories) were treated with 10 μL of 10 
μg/mL notexin (myoblast engraftment) or 18-Gy irradiation plus 20 μL of 10 μg/mL notexin 
(stem cell engraftment). One day later, 106 myoblasts stably expressing mNeptune1 or mCardinal, 
or 1000 or 5000 lentivirus-transduced stem cells expressing mCardinal, were suspended in 10 μL 
of PBS with 2% FBS and 1mM EDTA and slowly injected into each TA muscle. Images were 
acquired with the SZX12 fluorescence stereoscope equipped with the Retiga 4000RV cooled 
CCD digital camera. Imaging conditions were: for mCardinal, pE-100 35-W 615-nm LED 
(CooLED), 620/20 nm excitation filter, 667/30 nm emission filter; for Clover, MME250 250-W 
metal-halide lamp (Moritex), 475/30 nm excitation filter, 510 nm long-pass emission filter; for 
iRFP, MME250 250-W metal-halide lamp, 675/20 nm excitation filter, 730/30 nm emission filter. 
For bioluminescence, after intraperitoneal injection of 100 µL 30 mg/mL D-luciferin in PBS, a 
single 8-min exposure without binning was acquired on the IVIS Spectrum system. 
 
Data analysis and statistical methods. Images from IVIS Spectrum or non-IVIS systems were 
analyzed using Living Image 4.2 (Perkin-Elmer) or Fiji (http://fiji.sc/Fiji), respectively. 
Statistical tests were performed using GraphPad Prism v6.0. Multiple or single comparisons were 
performed with one-way ANOVA or two-tailed Student’s t tests, respectively, with significance 
level set at α = 0.05. F-tests were used to determine the equivalence of variance for single 
comparison, and t-tests assuming equal or unequal variances were selected accordingly. Brown-
Forsythe tests were used to determine the equivalence of variance for multiple comparisons, and 
one-way ANOVA with post-hoc tests of Dunnett (all mNeptune derivatives vs. mNeptune1, Fig. 
3) or Tukey (comparison between any two FPs, Supplementary Fig. 12) was performed. 
 
METHODS REFERENCES 
 
31. Shaner, N. C., Steinbach, P. A. & Tsien, R. Y. A guide to choosing fluorescent proteins. 
Nat Methods 2, 905-909 (2005). 
32. Walter, T. S. et al. Lysine methylation as a routine rescue strategy for protein 
crystallization. Structure 14, 1617-1622 (2006). 
33. Kabsch, W. XDS. Acta Crystallogr D Biol Crystallogr 66, 125-132 (2010). 
34. McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658-674 
(2007). 
35. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular 
structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221 (2010). 
36. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. 
Acta Crystallogr D Biol Crystallogr 66, 486-501 (2010). 
37. Praznikar, J., Afonine, P. V., Guncar, G., Adams, P. D. & Turk, D. Averaged kick maps: 
less noise, more signal. and probably less bias. Acta Crystallogr D Biol Crystallogr 65, 
921-931 (2009). 
38. Bass, R. B., Strop, P., Barclay, M. & Rees, D. C. Crystal structure of Escherichia coli MscS, 
a voltage-modulated and mechanosensitive channel. Science 298, 1582-1587 (2002). 
39. Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr D 
Biol Crystallogr 66, 22-25 (2010). 
40. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures 
by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53, 240-255 
(1997). 
41. Mello, C. C., Kramer, J. M., Stinchcomb, D. & Ambros, V. Efficient gene transfer in 
C.elegans: extrachromosomal maintenance and integration of transforming sequences. 
EMBO J 10, 3959-3970 (1991). 
42. Kerr, R. et al. Optical imaging of calcium transients in neurons and pharyngeal muscle of C. 
elegans. Neuron 26, 583-594 (2000). 
43. National Research Council (US) Committee on Guidelines for the Use of Animals in 
Neuroscience and Behavioral Research. Guidelines for the Care and Use of Mammals in 
Neuroscience and Behavioral Research (National Academies Press (US), Washington (DC), 
2003). 
 
 





Non-invasive intravital imaging of cellular differentiation with a bright red-excitable 
fluorescent protein  
 
Jun Chu, Russell D Haynes, Stéphane Y Corbel, Pengpeng Li, Emilio González-González, John 
S Burg, Niloufar J Ataie, Amy J Lam, Paula J Cranfill, Michelle A Baird, Michael W Davidson, 
Ho-Leung Ng, K Christopher Garcia, Christopher H Contag, Kang Shen, Helen M Blau & 
Michael Z Lin !
SUPPLEMENTARY INFORMATION 
 
 
  
Supplementary Figure 1. Amino acid sequences of mNeptune-related FPs  
 
 
 
Internal residues are highlighted in gray. Chromophore-forming residues are highlighted in red. 
Key differences between mKate2 and mNeptune1 are highlighted in orange. Differences between 
mNeptune1 and mNeptune2 are highlighted in blue. Key differences between mNeptune2 and 
mNeptune2.5 or mCardinal are highlighted in magenta. 
  
Supplementary Figure 2. Brightness of mNeptune-related proteins in vitro  
 
 
 
(a) Predicted emission curves upon excitation of equal concentrations of far-red FPs at 635 nm. 
To accurately reflect the number of photons emitted at each wavelength upon excitation at 635 
nm, for each FP, the area under the emission spectrum beyond 635 nm was normalized to the 
product of extinction coefficient at 635 nm and the quantum yield beyond 635 nm. (b) 
Fluorescence of purified far-red FPs at 1 mg/mL concentration in 200-μL reaction tubes. (c) 
Fluorescence in each image in (b) was normalized to mNeptune1 and charted. 
Supplementary Figure 3. Two-photon excitation spectra of mCardinal and mNeptune1  
 !
 
 
Two-photon excitation spectra were measured on purified proteins with a customized upright 
microscope (Prairie Technologies) equipped with a Olympus 40× water-immersion objective 
(NA 0.8), a red-sensitive Hamamatsu PMT and a mode-locked Ti:Sapphire laser (140-fs pulse 
width; 80 MHz repetition rate; Chameleon Ultra II, Coherent). Briefly, purified proteins in PBS 
(64 μM or 2 mg/mL) proteins or PBS were loaded into 12-well plate as 1.6 mL/well. The 
excitation wavelengths from 800 to 1080 nm with 20 nm intervals were changed manually and 
the power after objective for each wavelength was measured using a power meter.  Fluorescence 
images were acquired through a far-red emission filter HQ 645/70 nm (Chroma) and analyzed in 
Fiji software. The fluorescence subtracted by PBS was normalized to the square of the power 
after objective. All fluorescence was normalized to the fluorescence intensity of mNeptune1 at 
1080 nm. Inset: fluorescence normalized to respective fluorescence intensity at 1080 nm. 
 
 
!  
Supplementary Figure 4. Characterization of far-red FPs 
 
 
 
(a) Maturation kinetics at 37°C. Lysates from bacteria expressing FPs in anaerobic conditions 
were prepared beginning at time 0 and fluorescence measured over time. Mean of triplicate 
measurements are shown. (b) Green and red emissions detected upon excitation with 460 nm 
light. Colors are as in (a). (c) pH dependence of fluorescence. Colors are as in (a). (d) Semi-
Native PAGE. 10 mg of each protein was electrophoresed on a 4-12% Bis-Tris gel with buffer 
containing 0.1% SDS, then imaged on a blue LED transilluminator with an orange acrylic filter. 
GFP and tdTomato were used as the monomeric and dimeric native protein standards, 
respectively.   
 
 
 
 
  
Supplementary Figure 5. Photostability of far-red FPs  !
 
 
(a) Photobleaching kinetics of purified proteins in oil under arc lamp illumination with a 615/20 
nm excitation filter. Each curve is the mean of three independent experiments. (b, c) 
Photobleaching kinetics under arc lamp (b) or laser (c) illumination of mCardinal, mKate2, and 
mNeptune1 fused to histone H2B in living HeLa S3 cells. Each curve is the mean of at least 
three independent experiments.  
   
Supplementary Figure 6. Comparison of mNeptune-related FPs in HeLa cells 
 
 
 
(a) Schematics of the plasmids used for co-expression of far-red FPs and firefly luciferase 
separated by a P2A peptide. (b) Fluorescence images of HeLa cells expressing fluorescent 
proteins and luciferase. The images were acquired 30 h after transfection with a 615/30 nm 
excitation filter and a 665/40 nm emission filter. Scale bars, 30 μm. (c) Graph of fluorescence 
intensities normalized to luciferase activity. The data are presented as the mean ± SEM, n = 3. 
 
 
   
Supplementary Figure 7. Imaging of far-red FPs in neurons and myocytes  
 
(a) Rat embryonic day 18 hippocampal neurons were cotransfected with pcDNA3-Clover and a 
pcDNA3 plasmid expressing a far-red FP. Imaging was performed 12 days post-transfection 
using a 615/30 nm excitation filter and a 675/50 nm emission filter. Scale bars, 20 μm. (b) 
mCardinal expression in undifferentiated (left) and differentiating (right) primary mouse 
myoblasts. Scale bars, 20 μm. 
Supplementary Figure 8. Performance of mNeptune2 fusions in mammalian cells 
 
Cells were imaged with 633 nm laser excitation and a Cy5 emission filter. Fusions at the 
mCardinal N-terminus: (a) VASP-10aa-mNetpune2 (mouse; Vasodilator-stimulated 
phosphoprotein; focal adhesions), (c) EB3-7aa-mNeptune2 (human; Microtubule-associated 
protein RP/EB family member 3; the plus end of microtubules), (e) PDHA1-10aa-mNeptune2 
(human; pyruvate dehydrogenase, mitochondria), (g) keratin-17aa-mNeptune2 (human; 
intermediate filaments; cytokeratin 18), (h) PMP-10aa-mNeptune2 (human; peroxisomal 
membrane protein; peroxisomes), (i) mannosidaseII-10aa-mNeptune2 (mouse; the Golgi 
complex), (j) calnexin-14aa-mNeptune2 (human; endoplasmic reticulum). Fusions at the 
mCardinal C-terminus: (b) mNeptune2-7aa-Rab5a (canine; Rab5a; endosomes), (d) mNeptune2-
18aa-α-tubulin (human; microtubules), (f) mNeptune2-10aa-lamin B1 (human; nuclear 
envelope), (k) mNeptune2-15aa-Clathrin (human; clathrin light chain B) and (l) mNeptune2-
18aa-β-actin (human; actin cytoskeleton). The number followed by “aa” refers to the linker 
length in aa. Scale bars, 10 μm. 
 
 
! !
Supplementary Figure 9. Performance of mCardinal fusions in mammalian cells 
 
Cells were imaged with 633 nm laser excitation and a Cy5 emission filter. (a-h) Fusions at the 
mCardinal C-terminus: (a) mCardinal-18aa-β-actin (actin cytoskeleton), (b) mCardinal-18aa-α-
tubulin (microtubules), (c) mCardinal-5aa-CAAX (20-aa H-Ras farnesylation signal, plasma 
membrane), (d) mCardinal-10aa-lamin B1 (nuclear envelope), (e) mCardinal-14aa-myotilin 
(actin cytoskeleton), (f) mCardinal-14aa-ZO1 (tight junctions), (g) mCardinal-7aa-Rab5a 
(endosomes), (h) mCardinal-7aa-fibrillarin (nucleoli). (i-t) Fusions at the mCardinal N-terminus: 
(i) CENPB-22aa-mCardinal (centromeres), (j) VE-Cadherin-10aa-mCardinal (tight junctions), 
(k) vimentin-7aa-mCardinal (intermediate filaments), (l) calnexin-14aa-mCardinal (endoplasmic 
reticulum), (m) cytokeratin18-17aa-mCardinal (intermediate filaments), (n) PMP-10aa-
mCardinal (peroxisomal membrane protein), (o) mannosidaseII-10aa-mCardinal (Golgi 
complex), (p) Lifeact-7aa-mCardinal (yeast; actin), (q) α-actinin-19aa-mCardinal (actin and 
focal adhesions), (r) PDHA1-10aa-mCardinal (pyruvate dehydrogenase, mitochondria), (s) 
connexin43-7aa-mCardinal (gap junctions), (t) paxillin-22aa-mCardinal (focal adhesions). HeLa 
cells are shown except for (f), in which MDCK cells are shown. All fused domains are of human 
species, except for (g) canine Rab5a, (o) mouse mannosidaseII, (p) yeast Lifeact, (s) rat 
connexin43, and (t) chicken paxillin. The number followed by “aa” refers to the linker length in 
aa. Scale bars, 10 μm. 
Supplementary Figure 10. Performance of a histone-mCardinal fusion 
 
 
 
Widefield fluorescence imaging was performed on HeLa cells expressing a histone-mCardinal 
fusion protein with 633 nm laser excitation and a Cy5 emission filter. Human histone H1 was 
fused to the N-terminus of mCardinal via a 10-aa linker. (a) interphase, (b) prophase, (c) 
prometaphase, (d) metaphase, (e) anaphase, (f) telophase.  Scale bars, 10 μm. 
 
 
  
Supplementary Figure 11. Three-color imaging in C. elegans using mCardinal  
 
(a) Colocalization of Rab-3 (GFP::Rab-3) and synaptogyrin (SNG-1::mCardinal) in presynaptic 
vesicles of DA9 (dorsal) and VA12 (ventral) neurons. The fluorescent puncta correspond to 
presynaptic vesicles along the body wall muscles labeled with DsRed. In the merged image, 
pseudocolors were assigned as follows: cyan, GFP; yellow, DsRed; and Magenta, mCardinal. 
Arrows indicate the colocalization of Rab-3 and SNG-1. Anterior (A), posterior (P), dorsal (D), 
ventral (V). Scale bar, 10 μm. (b) Three-color imaging of vulva. Vulva muscle, primary and 
secondary vulva epithelial cells were labeled by mCD8::mCherry, GFP and mCardinal, 
respectively. Arrows indicate the muscle arms of type-2 vulval muscle (VM2). Scale bar, 5 μm. 
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Supplementary Figure 12. Comparison of mCardinal with iRFP in cells in deep tissue  !
 
 
(a) Representative fluorescence images of mice expressing mCardinal or iRFP in livers. Nude 
mice were injected hydrodynamically with 40 μg plasmid DNA expressing FPs driven by a CAG 
promoter. Images were acquired in epifluorescence mode with 3 filter sets indicated in (a) 40 h 
after injection. The color bar indicates the signal/background ratio. Scale bars represent 2 cm. (b) 
Quantification of fluorescence signal over background. Bars are mean ± SEM of 4 replicates. 
Differences are statistically significant by one-way ANOVA (P < 0.01). Asterisks indicate 
significant differences by Tukey’s multiple comparison test (*P < 0.05, **P < 0.01).   
Supplementary Figure 13. Repeatability of deep-tissue fluorescence imaging  
 
 
(a) Fluorescence images of mCardinal-expressing muscle fibers from the same leg with a 5 min 
time interval. A SCID mouse was injected with one million stable myoblasts expressing 
mCardinal. At 40 days after injection, the mouse was anesthetized and fluorescence images were 
acquired using the same imaging conditions as Fig. 4a except exposure time was increased to 20 
s. Measured irradiance at the specimen plane was 3.6 mW/cm2, corresponding to an energy 
exposure of 0.072 J/cm2 per frame. Scale bars, 2 mm. (b) Quantification of fluorescence signal 
subtracted by background.   
Supplementary Figure 14. Validation of minicircle constructs expressing far-red FPs and iRFP 
 
 
 
(a) Schematics of minicircles containing mNeptune1 or mCardinal and iRFP, separated with a 
P2A sequence. (b) Fluorescence images of stable myoblasts expressing the constructs shown in 
(a) (top two rows) and transiently transfected HEK293A cells with a pcDNA3 plasmid 
expressing FP (bottom three rows). Far-red and infrared fluorescence were acquired through far-
red (615/30 nm excitation, 630 nm dichroic, and 675/50 nm emission) and infrared filters 
(682/22 nm excitation, 700 nm dichroic, and 710 nm longpass emission) respectively. All images 
are normalized to the same intensity scale. Scale bars, 20 μm.  
!Supplementary Figure 15. Filter sets used to image mCardinal and iRFP!
!
!!
Excitation and emission spectra (left y-axis) of mCardinal and iRFP superimposed over 
optimized filters (right y-axis) to image far-red and infrared FPs.   
Supplementary Figure 16. Constructs for expressing far-red FPs and Clover in stem cells !
 !
(a) Schematics of the lentivirus construct used to infect stem cells. mCardinal, Clover, luciferase 
are separated by an IRES element from encephalomyocarditis virus and a 2A peptide from 
porcine teschovirus-1, respectively. (b) Fluorescence images of HEK293A cells expressing the 
construct shown in (a). Scale bar, 20 μm.   
Supplementary Table 1: Data collection and refinement statistics  
 mCardinal mCardinal V218E 
Data collection   
 Space group P1211 P212121 
 Cell dimensions a, b, c (Å) 53.2, 136.7, 167.6 72.5, 102.9, 116.5 
 Cell angles α, β, γ 90.0, 90.1, 90.0 90.0, 90.0, 90.0 
 Wavelength (Å) 1.0 1.115834 
 Resolution (Å) 47.56-2.21 (2.29-2.21)* 45.44-1.70 (1.80-1.70)* 
 Rsym or Rmerge 0.132 (0.800)* 0.052 (0.574)* 
 CC1/2 0.978 (0.261)* 0.999 (0.845)* 
 CC* 0.994 (0.643)* 1.000 (0.957)* 
 I/σI 5.61 (1.14)* 16.33 (2.21)* 
 Completeness (%) 94.8 (93.8)* 98.6 (96.3)* 
 Redundancy 1.9 (1.9)* 4.12 (4.14)* 
Refinement   
 Rwork/ Rfree 0.2225/0.2511 0.1600/0.1934 
 R.m.s deviations, bond lengths (Å) 0.004 0.012 
 R.m.s deviations, bond angles (º)             0.85 1.34 
*Highest resolution shell is shown in parenthesis. !!
 
  
Supplementary Video 1. Time-lapse laser-scanning confocal fluorescence microscopy imaging 
of a mCardinal-18aa-actin fusion protein targeting actin filaments in a fox lung fibroblast. 
Frames were acquired 18 s apart with a 633 nm laser and a 60× objective. Playback was encoded 
at 15 frames per s. 
 
Supplementary Video 2. Time-lapse laser-scanning confocal fluorescence microscopy imaging 
of a PDHA1-10-aa-mCardinal fusion protein targeting mitochondria in an NIH3T3 fibroblast. 
Frames were acquired 15 s apart with a 633 nm laser and a 60× objective. Playback was encoded 
at 15 frames per s. 
 
Supplementary Video 3. Fast time-lapse laser-scanning confocal fluorescence microscopy 
imaging of freely moving C.elegans with mCardinal-labeled pharynx. Frames were acquired 125 
ms apart with a 635 nm laser and a 20× objective (NA=0.75). Power measured at the specimen 
was 100 µW, corresponding to an irradiance of 0.030 J/cm2 per frame. Playback was encoded at 
7 frames per s. 
 
Supplementary Video 4. Fast time-lapse laser-scanning confocal fluorescence microscopy 
imaging of partially immobilized C.elegans with mCardinal-labeled pharynx. Worms were 
partially immobilized by dotting cyanoacrylate glue on their tails. 1 mg/mL serotonin in M9 was 
added to keep the sample hydrated during recordings and to induce pharyngeal pumping. Frames 
were acquired 125 ms apart with a 635 nm laser and a 20× objective (NA=0.75). Power 
measured at the specimen was 100 µW, corresponding to an irradiance of 0.030 J/cm2 per frame. 
Playback was encoded at 7 frames per s. 
 
 
